JG-23
N/A
Report date: 2022/01/10 18:08:26
NME
Base Information
Drug NameJG-23
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of California, San Francisco FresnoXiangya Hospital Of Central South University
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of California, San Francisco FresnoXiangya Hospital Of Central South University
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A